Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs
Source abstract
Abstract
In this study, a Soluplus-coated colloidal silica nanomatrix (SCCSN) formulation for the entrapment of poorly water-soluble drugs was devised. The maximum supersaturation of the drug-loaded nanomatrix was higher than that of a physical mixture as indicated by the results of in vitro kinetic solubility studies. For atorvastatin calcium, dutasteride, and sorafenib tosylate, there were 2.8-, 326-, and 46.4-fold increases in solubility, respectively. For dutasteride, a promising 4.7-fold increase for in vivo oral drug absorption in the entrapped nanomatrix was observed as compared to the free physical mixture, supported by statistical significance testing of pharmacokinetic parameters.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Solubulity and Delivery Systems · Crystallization and Solubility Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (24)
Show source-provided references
1. Baek IH · Chem Pharm Bull · 2012 · 60 · 146810.1248/cpb.c12-00563 ↗
2. Chauhan B · Eur J Pharm Sci · 2005 · 26 · 21910.1016/j.ejps.2005.06.005 ↗
3. Davis ME · Nat Rev Drug Discov · 2008 · 7 · 77110.1038/nrd2614 ↗
4. 10.1016/j.ejpb.2005.08.01310.1016/j.ejpb.2005.08.013 ↗
5. Ilevbare GA · Crystal Growth Des · 2012 · 12 · 313310.1021/cg300325p ↗
6. Jia Z · Eur J Pharm Biopharm · 2011 · 79 · 12610.1016/j.ejpb.2011.05.009 ↗
7. Kim MS · Eur J Pharm Biopharm · 2008 · 69 · 45410.1016/j.ejpb.2008.01.007 ↗
8. Kim MS · Int J Nanomedicine · 2011 · 6 · 2997
9. Kinnari P · Int J Pharm · 2011 · 414 · 14810.1016/j.ijpharm.2011.05.021 ↗
10. Kojima T · Pharm Res · 2012 · 29 · 277710.1007/s11095-011-0655-7 ↗
11. Limnell T · J Pharm Sci · 2011 · 100 · 329410.1002/jps.22577 ↗
12. Linn M · Eur J Pharm Sci · 2012 · 45 · 33610.1016/j.ejps.2011.11.025 ↗
13. Mamaeva V · Adv Drug Deliv Rev · 2012
14. Miura H · Chem Pharm Bull · 2011 · 59 · 68610.1248/cpb.59.686 ↗
15. Nagy ZK · J Pharm Sci · 2012 · 101 · 32210.1002/jps.22731 ↗
16. Overhoff KA · Pharm Res · 2008 · 25 · 16710.1007/s11095-007-9417-y ↗
17. Souris JS · Biomaterials · 2010 · 31 · 556410.1016/j.biomaterials.2010.03.048 ↗
18. Van Eerdenbrugh B · Eur J Pharm Sci · 2009 · 38 · 27010.1016/j.ejps.2009.08.002 ↗
19. Vivero-Escoto JL · Small · 2010 · 6 · 195210.1002/smll.200901789 ↗
20. Wang L · Chem Pharm Bull · 2006 · 54 · 3710.1248/cpb.54.37 ↗
21. 10.1016/j.ijpharm.2011.08.00310.1016/j.ijpharm.2011.08.003 ↗
22. 10.3109/1061186X.2010.52565210.3109/1061186X.2010.525652 ↗
23. Wen H · J Colloid Interface Sci · 2005 · 290 · 32510.1016/j.jcis.2005.04.049 ↗
24. 10.1021/mp200287c10.1021/mp200287c ↗